EZH2 and diabetic kidney disease: We recently reported that AGEs reduce EZH2 expression in podocytes, lowering the repressive mark H3K27me3 and inducing the expression of Snai1, p27Kip1, and Tgf-β, thereby promoting podocytes damage and diabetic nephropathy [18].